Arkolith/Insider Trading/CDTX/Form 4

Stein Jeffrey

President & CEO, DirectorCidara Therapeutics, Inc. (CDTX) · full profile →Form 4 · filed Jan 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
3 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Disposed to issuer(D)6K$221.50$1.3M0
Jan 7, 2026Disposed to issuer(D)67K$221.50$15.0M0
Jan 7, 2026Disposed to issuer(D)2K$221.50$527K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Disposed to issuer(D)16K——0
Jan 7, 2026Disposed to issuer(D)27K——0
Jan 7, 2026Disposed to issuer(D)52K——0
Jan 7, 2026Disposed to issuer(D)561K——0
Jan 7, 2026Disposed to issuer(D)275K——0
Jan 7, 2026Disposed to issuer(D)8K——0
Jan 7, 2026Disposed to issuer(D)11K——0
Jan 7, 2026Disposed to issuer(D)12K——0
Jan 7, 2026Disposed to issuer(D)13K——0
Jan 7, 2026Disposed to issuer(D)16K——0
Jan 7, 2026Disposed to issuer(D)26K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001478831-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Cidara Therapeutics, Inc.

Build

Ask your agent about CDTX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001478831-26-000005"
Ask your agent
Use Arkolith to summarize insider buying and selling at Cidara Therapeutics, Inc.
over the last 90 days and cite the filings.